Calyxt, Inc. (NASDAQ:CLXT) had its price target dropped by investment analysts at Citigroup Inc. from $27.00 to $22.00 in a research note issued to investors on Thursday. The brokerage currently has a “neutral” rating on the stock. Citigroup Inc.’s price objective indicates a potential upside of 22.63% from the stock’s previous close.
Other equities research analysts have also recently issued reports about the company. Wells Fargo & Company started coverage on Calyxt in a research note on Monday, August 14th. They issued an “outperform” rating and a $17.00 price objective for the company. Jefferies Group LLC started coverage on Calyxt in a research note on Monday, August 14th. They issued a “buy” rating and a $16.00 price objective for the company. BMO Capital Markets started coverage on Calyxt in a research note on Monday, October 30th. They issued an “outperform” rating and a $32.00 price objective for the company. Finally, Zacks Investment Research cut Calyxt from a “hold” rating to a “sell” rating in a research note on Monday, October 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $27.75.
Calyxt (NASDAQ:CLXT) traded down $1.24 during mid-day trading on Thursday, reaching $17.94. The company’s stock had a trading volume of 53,500 shares, compared to its average volume of 87,265. Calyxt has a one year low of $9.26 and a one year high of $31.89.
A number of large investors have recently added to or reduced their stakes in the stock. California State Teachers Retirement System purchased a new position in Calyxt in the third quarter valued at $323,000. Schwab Charles Investment Management Inc. purchased a new position in Calyxt in the third quarter valued at $358,000. American International Group Inc. purchased a new position in Calyxt in the third quarter valued at $133,000. Finally, Bank of New York Mellon Corp purchased a new position in Calyxt in the third quarter valued at $542,000. Hedge funds and other institutional investors own 0.11% of the company’s stock.
Calyxt Company Profile
Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.
Receive News & Ratings for Calyxt Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt Inc. and related companies with MarketBeat.com's FREE daily email newsletter.